Corrigendum to "IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling" [Int. Immunopharmacol. 141 (2024) 112966]

Int Immunopharmacol. 2024 Dec 25:113907. doi: 10.1016/j.intimp.2024.113907. Online ahead of print.
No abstract available

Publication types

  • Published Erratum